Leyre Silva

576 total citations
17 papers, 438 citations indexed

About

Leyre Silva is a scholar working on Immunology, Oncology and Hepatology. According to data from OpenAlex, Leyre Silva has authored 17 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 5 papers in Oncology and 5 papers in Hepatology. Recurrent topics in Leyre Silva's work include Immunotherapy and Immune Responses (10 papers), Hepatitis C virus research (5 papers) and Immune Cell Function and Interaction (5 papers). Leyre Silva is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), Hepatitis C virus research (5 papers) and Immune Cell Function and Interaction (5 papers). Leyre Silva collaborates with scholars based in Spain, United States and United Kingdom. Leyre Silva's co-authors include Pablo Sarobe, Juan José Lasarte, Diana Llópiz, Marta Ruiz, Bruno Sangro, Lorea Villanueva, Josune Egea, Tamara Iglesias, B. Vasseur and Aintzane Zabaleta and has published in prestigious journals such as Hepatology, Infection and Immunity and Frontiers in Immunology.

In The Last Decade

Leyre Silva

17 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Leyre Silva Spain	12	218	135	134	121	72	17	438
Sarah Goddard United Kingdom	6	264 1.2×	87 0.6×	50 0.4×	100 0.8×	87 1.2×	12	411
Céline Miroux France	10	182 0.8×	78 0.6×	42 0.3×	70 0.6×	61 0.8×	11	326
Alice Kok Netherlands	10	225 1.0×	62 0.5×	92 0.7×	120 1.0×	104 1.4×	11	488
Hiroshi Mitsuta Japan	11	338 1.6×	76 0.6×	55 0.4×	243 2.0×	132 1.8×	20	654
Yanling Sun China	9	244 1.1×	58 0.4×	59 0.4×	265 2.2×	286 4.0×	17	596
Li Xiao China	11	67 0.3×	47 0.3×	108 0.8×	62 0.5×	48 0.7×	19	351
Esther Unitt United Kingdom	7	445 2.0×	258 1.9×	61 0.5×	303 2.5×	187 2.6×	9	736
Susanne Auffermann-Gretzinger Germany	8	458 2.1×	77 0.6×	108 0.8×	188 1.6×	142 2.0×	9	610
Alice R. Burton United Kingdom	11	522 2.4×	128 0.9×	62 0.5×	341 2.8×	466 6.5×	14	916
Oliver E. Amin United Kingdom	7	318 1.5×	89 0.7×	52 0.4×	227 1.9×	300 4.2×	10	572

Countries citing papers authored by Leyre Silva

Since Specialization

Citations

This map shows the geographic impact of Leyre Silva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leyre Silva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leyre Silva more than expected).

Fields of papers citing papers by Leyre Silva

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leyre Silva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leyre Silva. The network helps show where Leyre Silva may publish in the future.

Co-authorship network of co-authors of Leyre Silva

This figure shows the co-authorship network connecting the top 25 collaborators of Leyre Silva. A scholar is included among the top collaborators of Leyre Silva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leyre Silva. Leyre Silva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Llópiz, Diana, et al.. (2025). MERTK inhibition improves therapeutic efficacy of immune checkpoint inhibitors in hepatocellular carcinoma. OncoImmunology. 14(1). 2473165–2473165. 2 indexed citations

Ruiz, Marta, Noëlia Casares, Leyre Silva, et al.. (2023). Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies. Frontiers in Immunology. 13. 1044025–1044025. 1 indexed citations

Ruiz, Marta, Leyre Silva, Josune Egea, et al.. (2022). Gemcitabine-mediated depletion of immunosuppressive dendritic cells enhances the efficacy of therapeutic vaccination. Frontiers in Immunology. 13. 991311–991311. 5 indexed citations

Ruiz, Marta, Diana Llópiz, Leyre Silva, et al.. (2022). Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancer. Frontiers in Immunology. 13. 985886–985886. 12 indexed citations

Llópiz, Diana, Marta Ruiz, Leyre Silva, et al.. (2020). Inhibition of adjuvant-induced TAM receptors potentiates cancer vaccine immunogenicity and therapeutic efficacy. Cancer Letters. 499. 279–289. 8 indexed citations

Silva, Leyre, Josune Egea, Lorea Villanueva, et al.. (2020). Cold-Inducible RNA Binding Protein as a Vaccination Platform to Enhance Immunotherapeutic Responses against Hepatocellular Carcinoma. Cancers. 12(11). 3397–3397. 23 indexed citations

Llópiz, Diana, Marta Ruiz, Leyre Silva, & Pablo Sarobe. (2018). Enhancement of Antitumor Vaccination by Targeting Dendritic Cell-Related IL-10. Frontiers in Immunology. 9. 1923–1923. 17 indexed citations

Llópiz, Diana, Marta Ruiz, Lorea Villanueva, et al.. (2018). Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model. Cancer Immunology Immunotherapy. 68(3). 379–393. 116 indexed citations

Villanueva, Lorea, Leyre Silva, Diana Llópiz, et al.. (2017). The Toll like receptor 4 ligand cold-inducible RNA-binding protein as vaccination platform against cancer. OncoImmunology. 7(4). e1409321–e1409321. 19 indexed citations

10.

Llópiz, Diana, Marta Ruiz, Lorea Villanueva, et al.. (2016). IL-10 expression defines an immunosuppressive dendritic cell population induced by antitumor therapeutic vaccination. Oncotarget. 8(2). 2659–2671. 40 indexed citations

11.

Zabaleta, Aintzane, Delia D’Avola, Diana Llópiz, et al.. (2015). Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis C virus infection. Molecular Therapy — Methods & Clinical Development. 2. 15006–15006. 16 indexed citations

12.

Garza, Rocío García de la, Pablo Sarobe, Juana Merino, et al.. (2015). Immune monitoring of immunosuppression withdrawal of liver transplant recipients. Transplant Immunology. 33(2). 110–116. 19 indexed citations

13.

Garza, Rocío García de la, Pablo Sarobe, Juana Merino, et al.. (2013). Trial of complete weaning from immunosuppression for liver transplant recipients: Factors predictive of tolerance. Liver Transplantation. 19(9). 937–944. 70 indexed citations

14.

Pereboev, Alexander, Leyre Silva, Aintzane Zabaleta, et al.. (2011). Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cells. Hepatology. 54(1). 28–37. 22 indexed citations

15.

Zabaleta, Aintzane, Leyre Silva, Nancy Díaz‐Valdés, et al.. (2008). Monocyte‐derived dendritic cells from HCV‐infected patients transduced with an adenovirus expressing NS3 are functional when stimulated with the TLR3 ligand poly(I:C). Journal of Viral Hepatitis. 15(11). 782–789. 11 indexed citations

16.

Zabaleta, Aintzane, Diana Llópiz, Laura Arribillaga, et al.. (2007). Vaccination Against Hepatitis C Virus With Dendritic Cells Transduced With an Adenovirus Encoding NS3 Protein. Molecular Therapy. 16(1). 210–217. 29 indexed citations

17.

Perraut, Ronald, Odile Mercereau‐Puijalon, Denise Mattei, et al.. (1995). Induction of opsonizing antibodies after injection of recombinant Plasmodium falciparum vaccine candidate antigens in preimmune Saimiri sciureus monkeys. Infection and Immunity. 63(2). 554–562. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact